Skip to main content

Advertisement

Table 6 Risk factors of VRE among HIV positive and HIV negative clients at Gondar University Teaching Hospital, Northwest Ethiopia, 2013

From: Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: a cross-sectional study

Risk factors Enterococci Total Number (%) P-value AOR (95% CI)
VRE VSE
Number (%) Number (%)
Antibiotic treatment (>2 weeks)      
Yes 10 (9.6) 94 (90.4) 104 (51.7) 0.01 10.21 (1.31 – 217.40)
No 1 (1.0) 96 (99.0) 97 (48.3) --- 1.00
CD4 *      
≤350 5 (11.4) 39 (88.6) 44 (42.7) 0.21 2.39 (0.46 – 13.57)
>350 3 (5.1) 56 (94.9) 59 (57.3) --- 1.00
HAART      
Yes* 8 (7.8) 94 (92.2) 102 (50.7) 0.13 2.72 (0.63 – 13.40)
No 3 (3.0) 96 (97.0) 99 (49.3) --- 1.00
HAART Duration (Year)*      
≤2 2 (6.7) 28 (93.3) 30 (29.1) --- 1.00
>2 6 (8.2) 67 (91.8) 73 (70.9) 0.57 1.25 (0.21 – 9.62)
WBC counts      
Normal 11 (6.6) 156 (93.4) 167 (83.1) --- 1.00
Leucopenic 0 (0) 27 (100) 27 (13.4) 0.18 0.00 (0.00 – 2.92)
Leucocytosis 0 (0) 7 (100) 7 (3.5) 0.62 0.00 (0.00 – 12.95)
Platelet      
Normal 10 (5.6) 168 (94.4) 188 (88.6) --- 1.00
Thrombocytopenic 0 (0) 12 (100) 12 (6.0) 0.51 0.00 (0.00 – 8.40)
Thrombocytosis 1 (9.1) 10 (90.9) 11 (5.4) 0.49 1.68 (NA)
Nutritional status      
Normal 8 (4.7) 161 (95.3) 169 (84.1) --- 1.00
Malnourished 2 (13.3) 13 (86.7) 15 (7.5) 0.19 3.10 (0.41 – 18.57)
Overweight 1 (5.9) 16 (94.1) 17 (8.5) 0.59 1.26 (NA)
Anemic      
Yes 11 (5.8) 179 (94.2) 190 (94.5) 0.52 UD
No 0 (0) 11 (100) 11 (5.5) --- 1.00
Drinking alcohol      
Yes 2 (3.4) 57 (96.6) 59 (29.4) 0.32 0.52 (0.07 – 2.69)
No 9 (6.3) 133 (93.7) 142 (70.6) --- 1.00
WHO stage*      
I 2 (8.3) 22 (91.7) 24 (23.3) --- 1.00
II 0 (0) 15 (100) 15 (14.6) 0.37 0.00 (0.00 – 6.91)
III 2 (6.7) 28 (93.3) 30 (29.1) 0.60 0.79 (0.07 – 8.68)
IV 4 (11.8) 30 (88.2) 34 (33.3) 0.51 1.470.20 – 12.82)
  1. *Only for HIV infected patients.